What makes surveillance different from a one-off survey or study?

Surveillance is ongoing and systematic, designed to monitor disease continuously and feed results back to those who act on them, whereas a survey or study is typically a discrete data-collection effort answering a specific question at one time.

Why is surveillance of chronic disease harder than for infectious disease?

Infectious diseases have a clear onset that can be notified case by case, but chronic diseases develop gradually and persist, so surveillance must rely on prevalence and risk-factor surveys, registries and mortality data rather than acute case reporting.

Disease Surveillance Systems

Disease surveillance systems are the ongoing, organised machinery for collecting, analysing and disseminating health data so that the burden and distribution of disease can be tracked over time. The classic definition emphasises continuous, systematic data collection tied to action; for chronic non-communicable disease, surveillance supplies the prevalence, incidence, risk-factor and mortality data on which burden estimates rest.

Definition

Disease surveillance is the ongoing systematic collection, analysis and interpretation of health data, closely integrated with timely dissemination to those responsible for prevention and control, used to monitor the occurrence and distribution of disease and its determinants in a population.

Scope

The entry covers what surveillance is, its core functions and data sources, the contrast between communicable-disease and chronic-disease surveillance, and how surveillance systems are evaluated. It is a methodological and infrastructural topic, not clinical guidance.

Core questions

What functions does surveillance perform, and how does it link data to action?
What data sources feed chronic-disease surveillance?
How does chronic-disease surveillance differ from communicable-disease surveillance?
How are surveillance systems evaluated for usefulness and quality?

Key concepts

Ongoing systematic data collection
Notifiable disease and case-based reporting
Sentinel and population surveillance
Registries (cancer, vital statistics)
Risk-factor and behavioural surveillance
System attributes (timeliness, sensitivity, representativeness)

Mechanisms

Surveillance gathers data through case reporting, registries, vital registration, health surveys and increasingly electronic records, then analyses them by person, place and time and disseminates the results to guide prevention. For chronic disease, where there is no single moment of onset to notify, surveillance leans on prevalence and risk-factor surveys, disease registries and cause-of-death systems rather than acute case reporting. Systems are appraised against attributes such as simplicity, sensitivity, timeliness, representativeness and usefulness.

Clinical relevance

Surveillance describes the population-level scale and trends of disease and underpins the data used in burden estimation and disparity monitoring. It characterises population health and the data infrastructure behind it, and is not a basis for individual diagnostic or treatment decisions.

Epidemiology

Chronic-disease surveillance draws on cancer registries, cardiovascular and diabetes monitoring, behavioural risk-factor surveys and vital statistics, and these national systems feed the inputs used by global synthesis efforts such as the Global Burden of Disease Study to estimate non-communicable disease burden and its distribution.

History

Modern public health surveillance was shaped at the US Communicable Disease Center under Alexander Langmuir, who articulated continuous data-to-action monitoring, and the concept was broadened and codified for the United States by Thacker and Berkelman in 1988. Standardised evaluation of surveillance systems was set out in guideline form, and surveillance has since expanded from infectious disease to chronic-disease and risk-factor monitoring.

Debates

Adapting surveillance to chronic disease: Surveillance methods built for acute notifiable infections fit chronic disease poorly because chronic conditions lack a clear onset to report; how best to monitor prevalence, risk factors and outcomes for non-communicable disease remains an active methodological question.

Key figures

Stephen Thacker
Ruth Berkelman
Alexander Langmuir
William Foege

Seminal works

thacker-berkelman-1988
german-2001

Frequently asked questions

What makes surveillance different from a one-off survey or study?: Surveillance is ongoing and systematic, designed to monitor disease continuously and feed results back to those who act on them, whereas a survey or study is typically a discrete data-collection effort answering a specific question at one time.
Why is surveillance of chronic disease harder than for infectious disease?: Infectious diseases have a clear onset that can be notified case by case, but chronic diseases develop gradually and persist, so surveillance must rely on prevalence and risk-factor surveys, registries and mortality data rather than acute case reporting.